GlassScriptPhysician profile
Kimberly Hunt
NPI 1144582081
$4,170.24
in general payments reported to CMS, 2019-2025
29 companies · $267 in 2025
The $267 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $448 · 2020: $151 · 2021: $128 · 2022: $271 · 2023: $1,808 · 2024: $1,097 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,330 · Travel and Lodging: $819 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,330.27 |
| Travel and Lodging | $818.69 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,597.95 | 2023-2024 | Da Vinci Surgical System |
| Supernus Pharmaceuticals, INC. | $1,263.96 | 2022-2025 | Qelbree, Qelbree |
| Abbvie INC. | $231.05 | 2019-2025 | |
| Aspira Women'S Health INC | $159.42 | 2021-2024 | Ova1 |
| Hologic Sales and Service, LLC | $116.49 | 2019-2023 | Aptima |
| Regeneron Healthcare Solutions, INC. | $89.28 | 2022-2023 | Dupixent |
| Atricure, INC. | $80.74 | 2025 | Atriclip Laa Exclusion System |
| Coopersurgical, INC. | $67.06 | 2024 | Summit Doppler |
| Merck Sharp & Dohme LLC | $61.63 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $50.17 | 2019-2020 | |
| Biogen, INC. | $41.24 | 2024 | |
| Roche Diagnostics Corporation | $40.36 | 2019-2020 | |
| Organon LLC | $34.23 | 2022-2024 | |
| Daiichi Sankyo INC. | $33.53 | 2019 | |
| Applied Medical Resources Corporation | $31.67 | 2023 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $31.28 | 2019 | |
| Vertical Pharmaceuticals, LLC | $29.42 | 2019 | |
| Kaleo, INC. | $27.28 | 2019-2020 | |
| Exeltis, USA INC. | $25.29 | 2019-2020 | |
| Astellas Pharma US INC | $23.29 | 2023 | Veozah |
| Mayne Pharma Commercial LLC | $18.97 | 2021 | |
| Ethicon US, LLC | $16.55 | 2019 | |
| Avanos Medical | $16.42 | 2019 | |
| Pharmacosmos Therapeutics INC. | $15.85 | 2021 | |
| Pfizer INC. | $14.66 | 2021 | |
| Minerva Surgical, INC | $14.33 | 2024 | |
| Collegium Pharmaceutical, INC. | $13.95 | 2025 | Jornay Pm |
| Myovant Sciences INC. | $12.70 | 2021 | |
| Olympus America INC. | $11.47 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Hunt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.